Up to $400,000 of funding available over two years. CSL’s Research Acceleration Initiative aims to fast-track the discovery of innovative biotherapies through partnerships between CSL and global research organizations. These partnerships provide funding and access to industry experts for scientists working on novel biotherapeutic strategies in CSL’s therapeutic areas. Pitt faculty are invited to submit pre-proposals by February 16, 2023.

Successful applicants receive up to $400,000 USD over two years and CSL scientific champions will be assigned to each project to provide expert, industry guidance.

Areas of Interest

New antibody/recombinant proteins, peptides, gene and cell therapies, oligonucleotides and/or technologies in the following fields:

---Immunology
---Hematology
---Respiratory
---Cardiovascular & Metabolic
---Transplant
---Vaccines

Informational Webinar #1: Jan 25, 1 p.m.

Informational Webinar #2: Feb 6, 4 p.m.